CYPH
CYPH
NASDAQ · Biotechnology

Cypherpunk Technologies Inc

$0.61
-0.02 (-3.57%)
As of Jun 30, 10:42 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +6,223.7% upside
Low Target $25.17
Average Target $38.72
High Target $55.57
Current Price $0.61
Current
$0.61
Target
$38.72
$25.17 $38.72 avg $55.57
Scenario Analysis
Bear Case
$25.17
4,010.7%
Low target
Base Case
$38.72
+6,223.7%
Avg target
Bull Case
$55.57
+8,975.6%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$3.70
-83.5% from high
52-Week Low
$0.23
+163.9% from low
Target vs 52W High
$38.72
+946.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%